Syndax Announces Pricing of Public Offering of Common Stock
- Thursday, April 30, 2020, 7:04
- Finance
- Add a comment
WALTHAM, Mass., April 30, 2020 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today the pricing of an underwritten public offering of…
About the Author
adminasapcorp has written 37652 stories on this site.